1624 search results found for “{{searchWord}}”
inter_project
EXCELLtoINNOV
EXCELLtoINNOV
Leverage research EXCELLence and INNOVation potential of iMM
startup
TechnoPhage
TechnoPhage
TechnoPhage is an innovative biopharmaceutical company engaged in the R&D of new molecules – chemical and biological – in diverse therapeutic areas, such as infection, inflammation & immunology, neurology and metabolic disorders.
startup
RoPlaVac
RoPlaVac
The mission of RoPlaVac is to develop medical solutions against malaria, one of the most prevalent diseases worldwide
startup
Lymphact
Lymphact
Lymphact is a biopharmaceutical start-up focused on developing innovative personalized medical treatments.
startup
GenoMed
GenoMed
The mission of GenoMed is to create value through leveraging scientific and technological knowledge.
news
New approach on the use of big data in clinical decision support
New approach on the use of big data in clinical decision support
A new computational approach that allows the identification of molecular alterations associated with prognosis and resistance to therapy of different types of cancer was developed by the research grould led by Nuno Barbosa Morais.
video
Bruno Silva-Santos explains the importance of the Nobel Prize in Physiology or Medicine 2018
Bruno Silva-Santos explains the importance of the Nobel Prize in Physiology or Medicine 2018
news
MyoChip | iMM leads European project to develop muscle-on-chip for biomedical applications
MyoChip | iMM leads European project to develop muscle-on-chip for biomedical applications
news
How cannabis and cannabis-based drugs harm the brain
How cannabis and cannabis-based drugs harm the brain
A new study led by Ana Sebastião, group leader at Instituto de Medicina Molecular João Lobo Antunes and Professor of Faculdade de Medicina of Universidade de Lisboa (iMM, FMUL; Portugal) and her team in collaboration with researchers from the University of Lancaster (UK), shows that the long-term use of either cannabis or cannabis-based drugs impairs memory.
news
Molecular Biosciences – Biology at the Host Microbe INTERFACE PhD Program
Molecular Biosciences – Biology at the Host Microbe INTERFACE PhD Program
The call for applications to the 2019 edition of the PhD Program Molecular Biosciences - Biology at the Host Microbe INTERFACE will be open between August 10, 2018, and October 15, 2018, at 16h00 Lisbon time. The program will start on February 1, 2019.
news
iMM researchers awarded by Fundação la Caixa and Iniciativa Ibérica de Investigação e Inovação Biomédica- i4b
iMM researchers awarded by Fundação la Caixa and Iniciativa Ibérica de Investigação e Inovação Biomédica- i4b
Maria Manuel Mota is one of the Portuguese recipients of eight Health Research grants from “la Caixa” Banking Foundation. Each researcher will receive up to 1 million euros for three years to develop their research projects in areas such as infectious diseases, neurosciences and metabolic diseases. Within this initiative, Miguel Castanho group leader at iMM and Professor at Faculdade de Medicina da Universidade de Lisboa is a collaborator of an awarded project coordinated by a Spanish research group.
on_the_media
Luís Graça | GPS – Global Portuguese Scientists
Luís Graça | GPS – Global Portuguese Scientists
on_the_media
Maria Mota is one of the Startup Portugal Ambassadors
Maria Mota is one of the Startup Portugal Ambassadors
news
New study reveals essential mechanism to generate healthy muscle
New study reveals essential mechanism to generate healthy muscle
A group of researchers led by Edgar Gomes, Group Leader at Instituto de Medicina Molecular João Lobo Antunes (iMM; Portugal) identifies in muscle cells a new mechanism that activates locally the movement of the nucleus to its correct position. This discovery, now published in the scientific journal Developmental Cell, can have important implications in therapeutic strategies to treat muscular diseases.
on_the_media
Edgar Gomes Lab | New Paper on Developmental Cell
Edgar Gomes Lab | New Paper on Developmental Cell
video
TwinnToInfect | Impact on institutions and research
TwinnToInfect | Impact on institutions and research
news
New study shows how gut immune cells are kept in control
New study shows how gut immune cells are kept in control
A new study led by Marc Veldhoen, group leader at Instituto de Medicina Molecular João Lobo Antunes (iMM; Portugal) shows how gut immune cells are kept under control.
news
New mechanism involved in memory loss associated with aging discovered
New mechanism involved in memory loss associated with aging discovered
A study led by Luísa Lopes, Group Leader at Instituto de Medicina Molecular João Lobo Antunes (iMM; Portugal) and published today in the prestigious journal Molecular Psychiatry, describes a new mechanism involved in memory loss associated with aging.
on_the_media
Luísa Lopes Lab | New Paper on Molecular Psychiatry
Luísa Lopes Lab | New Paper on Molecular Psychiatry
on_the_media
Marc Velddhoen Lab | New Paper on Science Immunology
Marc Velddhoen Lab | New Paper on Science Immunology
video
Instituto de Medicina Molecular João Lobo Antunes | iMM
Instituto de Medicina Molecular João Lobo Antunes | iMM
news
Fundo João Lobo Antunes
Fundo João Lobo Antunes
iMM was created in 2004 based on the vision of João Lobo Antunes to nurture the exchange of ideas between those who produce knowledge at the bench and the ones who practice medicine.
on_the_media
M. Carmo-Fonseca on ‘O Princípio da Incerteza’ Program
M. Carmo-Fonseca on ‘O Princípio da Incerteza’ Program
video
ReTuBi: Towards Outstanding Research and Training in Tumour Biology
ReTuBi: Towards Outstanding Research and Training in Tumour Biology
news
Scientists find novel mechanisms to avoid telomere instability found in cancer and aging cells
Scientists find novel mechanisms to avoid telomere instability found in cancer and aging cells
Researchers from Instituto de Medicina Molecular (iMM) João Lobo Antunes have found that a functional component of telomeres called TERRA has to constantly be kept in check to prevent telomeric and chromosomal instability, one of the underlying anomalies associated with cancer.